Luyu Yang
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Immunology top 5%
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immune cells in cancer
Papers in
-
- COVID-19 Clinical Research Studies 13
-
- Hepatocellular Carcinoma Treatment and Prognosis 5
- Co-authors
- Erzhen Chen (4 shared papers)Zhongheng Zhang (2 shared papers)Cheng Zhu (2 shared papers)Yuetian Yu (2 shared papers)Qiongfang Zha (1 shared paper)Han Zhong (1 shared paper)Zhi‐Chun Gu (1 shared paper)Yujie Li (1 shared paper)
- Journals
- Experimental Hematology and Oncology (2 papers)Annals of Translational Medicine (2 papers)Critical Care (2 papers)Frontiers in Immunology (2 papers)Journal of Cancer (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Luyu Yang
42 papers receiving 2.6k citations
Luyu Yang's Hit Papers
Peers
Comparison fields: 5 of 164
- Infectious Diseases 781
- Immunology 427
- Statistics, Probability and Uncertainty 183
- Hepatology 140
- Oncology 201
Countries citing papers authored by Luyu Yang
This map shows the geographic impact of Luyu Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luyu Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luyu Yang more than expected).
Fields of papers citing papers by Luyu Yang
This network shows the impact of papers produced by Luyu Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luyu Yang. The network helps show where Luyu Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Luyu Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A bibliometric analysis using VOSviewer of publications on COVID-19 Hit paper breakdown → | 2020 | 428 |
| 2 | 2020 | 372 | |
| 3 | 2020 | 301 | |
| 4 | 2020 | 209 | |
| 5 | 2020 | 178 | |
| 6 | 2020 | 155 | |
| 7 | Research progress of nanozymes in colorimetric biosensing: Classification, activity and application Hit paper breakdown → | 2024 | 144 |
| 8 | 2020 | 128 | |
| 9 | 2021 | 97 | |
| 10 | 2017 | 73 | |
| 11 | 2024 | 44 | |
| 12 | 2020 | 43 | |
| 13 | Interleukin-6 enhances cancer stemness and promotes metastasis of hepatocellular carcinoma via up-regulating osteopontin expression. | 2016 | 40 |
| 14 | 2021 | 38 | |
| 15 | 2020 | 35 | |
| 16 | 2022 | 35 | |
| 17 | 2022 | 35 | |
| 18 | 2018 | 33 | |
| 19 | 2020 | 32 | |
| 20 | 2024 | 31 |
About Luyu Yang
Luyu Yang is a scholar working on Infectious Diseases, Hepatology, Immunology, Oncology and Nephrology, having authored 46 papers that have together received 2.7k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (13 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cancer Immunotherapy and Biomarkers (3 papers), Biosensors and Analytical Detection (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Respiratory Support and Mechanisms (2 papers) and Single-cell and spatial transcriptomics (2 papers). The work is most often cited by research in Infectious Diseases (781 citations), Immunology (427 citations), Statistics, Probability and Uncertainty (183 citations), Hepatology (140 citations) and Oncology (201 citations). Luyu Yang has collaborated with scholars based in China and United States. Frequent co-authors include Erzhen Chen, Zhongheng Zhang, Cheng Zhu, Yuetian Yu, Qiongfang Zha, Han Zhong, Zhi‐Chun Gu, Yujie Li, Lun–Xiu Qin and Haoting Sun. Their work appears in journals such as Experimental Hematology and Oncology, Annals of Translational Medicine, Critical Care, Frontiers in Immunology and Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.